Search clinical trials for: hydroxychloroquine placebo

Total 53877 results

Institut de cancérologie Strasbourg Europe

Withdrawn

Study Evaluating the Efficacy of Hydroxychloroquine and Azithromycine in Patients With COVID-19 and Hematological Malignancies (HYACINTHE) (HYACINTHE)

Hematologic Malignancy | COVID19

France
Rutgers, The State University of New Jersey
National Cancer Institute (NCI); Rutgers Cancer Institute of New Jersey

Completed

Hydroxychloroquine in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancer

Prostate Cancer

United States
Rutgers, The State University of New Jersey

Terminated

Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19

COVID-19 | SARS-CoV-2

United States
Rutgers, The State University of New Jersey
National Cancer Institute (NCI); Rutgers Cancer Institute of New Jersey

Completed

Hydroxychloroquine in Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery

Melanoma (Skin)

United States
University Hospital Center of Martinique

Completed

Lupus and Observance (LUPOBS)

Systemic Lupus, Skin Lupus

France
Vanderbilt University

Completed

Hydroxychloroquine in Cystic Fibrosis

Cystic Fibrosis

United States
Henry Ford Health System

Terminated

Will Hydroxychloroquine Impede or Prevent COVID-19 (WHIP COVID-19)

Coronavirus Infections | COVID-19 | SARS-CoV 2 | Coronavirus

United States
University of Washington
Bill and Melinda Gates Foundation

Completed

Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP)

COVID-19 | Corona Virus Infection | SARS-CoV-2 | SARS (Severe Acute Respiratory Syndrome)

United States
NYU Langone Health

Completed

COVID-19 PrEP HCW HCQ Study

COVID-19

United States
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

Ixabepilone and Hydroxychloroquine in Treating Patients With Metastatic Breast Cancer

Breast Cancer

United States
Hackensack Meridian Health

Completed

Hydroxychloroquine as Chemoprevention for COVID-19 for High Risk Healthcare Workers

Covid19

United States
LLiu

Completed

Hydroxychloroquine Sulfate for Reduction of Proteinuria in Patients With IgA Nephropathy: a Self- Controlled Study

Primary IgA Nephropathy

China
Assistance Publique - Hôpitaux de Paris

Withdrawn

Acute Rhabdomyolysis and Muscle Pain Associated With Mutations in the LPIN1 Gene - A Retrospective Study Describing the Safety and Efficacy of Hydroxychloroquine Sulfate Given on a Compassionate Basis to Patients Suffering From Lipin-1 Deficiency (LIPIN-1-METAB)

LIPIN1 Deficiency

France
Assistance Publique - Hôpitaux de Paris
Sanofi-Synthelabo

Completed

The Reduction of Systemic Lupus Erythematosus Flares :Study PLUS

Systemic Lupus Erythematosus

France
University Medical Center Groningen

Completed

Local Tolerability and Pharmacokinetic Evaluation of Cyclops Dry Powder Hydroxychloroquine Inhalation in Healthy Volunteers

Covid19

Netherlands
Regional Center for Disease Control and Prevention...
Farhat Hached Hospital, Tunisia; Fattouma Bourguiba, Tunisia

Unknown

Chemoprevention Clinical Trial of COVID-19: Hydroxychloroquine Post Exposure Prophylaxis (APCC-19)

SARS-CoV Infection
Ministry of Health and Population, Egypt

Unknown

Ivermectin In Treatment of COVID 19 Patients

Covid19

Egypt
Makerere University

Active, not recruiting

Hydroxychloroquine for Treatment of Non-Severe COVID-19 (HONEST)

Covid19

Uganda
Texas Cardiac Arrhythmia Research Foundation

Withdrawn

Prophylactic Benefit of Hydroxychloroquine in COVID-19 Cases With Mild to Moderate Symptoms and in Healthcare Workers With High Exposure Risk (PREVENT)

COVID-19
Western Regional Medical Center

Terminated

Hydroxychloroquine in Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Hormonal Therapy (ABC01)

Estrogen Receptor Positive Breast Cancer

United States
Hospices Civils de Lyon

Unknown

MEK and Autophagy Inhibition in Metastatic/Locally Advanced, Unresectable Neuroblastoma RAS (NRAS) Melanoma (CHLOROTRAMMEL)

Metastatic NRAS Melanoma

France
Second Affiliated Hospital, School of Medicine,...

Recruiting

The Efficacy and Safety of Iguratimod (IGU) in the Treatment of Primary Sjögren's Syndrome

Primary Sjögren's Syndrome

China
Shanghai First Maternity and Infant Hospital
Fudan University; Xinhua Hospital, Shanghai Jiao Tong University School of... and other collaborators

Not yet recruiting

A Study of Hydroxychloroquine Sulfate in the Treatment of Recurrent Spontaneous Abortion With Antiphospholipid Syndrome

Recurrent Miscarriage | Antiphospholipid Syndrome

China
National Taiwan University Hospital
National Taiwan University

Recruiting

Using Hydroxychloroquine to Treat Nonalcoholic Steatohepatitis

Nonalcoholic Steatohepatitis

Taiwan
Abramson Cancer Center at Penn Medicine
Pfizer

Active, not recruiting

Binimetinib and Hydroxychloroquine in Patients With Advanced KRAS Mutant Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer | KRAS Mutation-Related Tumors

United States
Milton S. Hershey Medical Center
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Active, not recruiting

Study of Anti-Malarials in Incomplete Lupus Erythematosus (SMILE)

Systemic Lupus Erythematosus

United States
National Institute of Respiratory Diseases, Mexico

Completed

Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial) (PHYDRA)

Severe Acute Respiratory Syndrome | COVID-19

Mexico
National Institute of Allergy and Infectious Diseases...
Autoimmunity Centers of Excellence

Terminated

Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid Arthritis (StopRA)

Healthy Participants | Rheumatoid Arthritis (RA) Prevention

United States
Assiut University

Unknown

Genetic Variants in Egyptian Patients Receiving HCQ(Hydroxychloroquine) (HCQ)

Autoimmune Diseases
Cambridge University Hospitals NHS Foundation Trust
University of Cambridge

Withdrawn

PROphylaxis for paTiEnts at Risk of COVID-19 infecTion (PROTECT)

COVID-19
University of Pittsburgh
National Institutes of Health (NIH)

Terminated

Study of Hydroxychloroquine Before Surgery in Patients With Primary Renal Cell Carcinoma

Renal Cell Carcinoma

United States
University Hospital, Brest

Active, not recruiting

Hydroxychloroquine for Prevention of Recurrent Miscarriage. (BBQ)

Recurrent Miscarriage | First Trimester Abortion

France
Medical University of Vienna

Withdrawn

HCQ for Primary Prophylaxis Against COVID19 in Health-care Workers

Sars-CoV2 | Prophylaxis | Infection Viral | Healthcare Worker
Hospital Alemão Oswaldo Cruz
Hospital Israelita Albert Einstein; Hospital Moinhos de Vento; Hospital do Coracao and other collaborators

Completed

Randomized Placebo-controlled Trial of Hydroxychloroquine in Outpatient Cases With Coronavirus Disease 2019 (COVID-19) (COALITION-V)

COVID-19

Brazil
University Hospital Tuebingen
Universitätsklinikum Hamburg-Eppendorf; Robert Bosch Medical Center; Bernhard...

Terminated

Hydroxychloroquine for the Treatment of Mild COVID-19 Disease (COMIHY)

COVID-19

Germany
Hamad Medical Corporation

Unknown

Post Exposure Prophylaxis in Healthcare Workers Exposed to COVID-19 Patients (HCQ-COVID19)

COVID 19
National University of Malaysia

Recruiting

Hydroxychloroquine in Type 2 Diabetes During Pregnancy

Type 2 Diabetes | Diabetes in Pregnancy

Malaysia
Cornerstone Pharmaceuticals

Completed

To Evaluate Maximally Tolerated Dose (MTD), Safety and Efficacy of CPI-613® (Devimistat) Plus Hydroxychloroquine in Patients With Relapsed or Refractory Clear Cell Sarcoma of Soft Tissue

Sarcoma, Clear Cell

United States
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)

Completed

Hydroxychloroquine, Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

Colorectal Cancer

United States
Hugo Mendieta Zeron

Terminated

Hydroxychloroquine vs Nitazoxanide in Patients With COVID-19

Coronavirus Infection

Mexico
First Affiliated Hospital of Harbin Medical University

Unknown

Effect of Hydroxychloroquine on Atrial Fibrillation Recurrence

Atrial Fibrillation

China
Plan Nacional sobre el Sida (PNS)
Effice Servicios Para la Investigacion S.L.

Completed

Randomized Clinical Trial for the Prevention of SARS-CoV-2 Infection (COVID-19) in Healthcare Personnel (EPICOS)

Coronavirus Infection

Spain
Taoyuan General Hospital
National Health Research Institutes, Taiwan; Centers for Disease Control, Taiwan and other collaborators

Completed

Efficacy and Tolerability of Hydroxychloroquine in Adult Patients With COVID-19

Coronavirus Infection

Taiwan
Mansoura University

Unknown

Development and Validation of "Ready-to-Use" Inhalable Forms of Hydroxychloroquine for Treatment of COVID-19

Covid19 | Hydroxychloroquine Adverse Reaction

Egypt
West Virginia University

Recruiting

Neoadjuvant mFOLFIRINOX With Perioperative Oral Hydroxychloroquine in Resectable Pancreatic Adenocarcinoma

Adenocarcinoma of the Pancreas

United States
University Hospital, Angers

Terminated

Hydroxychloroquine Versus Placebo in COVID-19 Patients at Risk for Severe Disease (HYCOVID)

Coronavirus

France, Monaco
WellStar Health System

Unknown

Hydroxychloroquine Use in Hospitalized Patients With COVID-19: Impact on Progression to Severe or Critical Disease

COVID-19

United States
Vanderbilt University

Withdrawn

Hydroxychloroquine Efficacy in Chronic Urticaria

Chronic Urticaria
Cardresearch
Cytel Inc.; Cardresearch - Cardiologia Assistencial e de Pesquisa LTDA

Unknown

Hydroxychloroquine and Lopinavir/ Ritonavir to Improve the Health of People With COVID-19: "The Hope Coalition - 1"

COVID-19 | Coronavirus Infection | SARS-CoV Infection | Acute Respiratory Infection | Virus Disease

Brazil
Tan Tock Seng Hospital
Netherlands: Ministry of Health, Welfare and Sports; Duke-NUS Graduate Medical... and other collaborators

Withdrawn

Safety And Efficacy Of Hydroxychloroquine For At Risk Population (SHARP) Against COVID-19 (SHARP COVID-19)

Coronavirus Infection | Hydroxychloroquine Adverse Reaction

Search clinical trials for: hydroxychloroquine placebo

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Madagascar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations